Alena Khromava | Senior Director and Head of Pharmacoepidemiology and Risk Management
Sanofi Pasteur

Alena Khromava, Senior Director and Head of Pharmacoepidemiology and Risk Management, Sanofi Pasteur

Prior to joining Sanofi Pasteur in 2004, Alena completed Epidemic Intelligence Service at the US Centers for Disease Control and Prevention in Immunization Safety Branch. She also worked as a medical epidemiologist on STDs, HIV/AIDS and Multidrug resistant tuberculosis in Moscow, Russia. Alena is trained as Internal Medicine physician in Belarus (MD degree from Gomel State Medical University).

Her current area of interest is in advanced epidemiologic methods used in vaccine safety, novel data sources and quantitative benefit-risk assessment of vaccines.


Day 2, April 8 @ 17:10

Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

  • Evaluating vaccine safety in children and other at-risk populations
    • E.g. RSV and Pertussis, Live attenuated vs subunit
  • What are the benefits of RCTs and large databases and how can they be improved?
  • How can we ensure we are taking all parameters into account e.g. what time of year is the vaccine given?
  • How do we decide which signals are meaningful?
  • Do we need to revisit the influenza & narcolepsy issue?
  • The need for better databases in LMICs – how do you recognize safety signals? How can they be implemented?
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates